Eurofins Scientific seals an outsourcing deal with Astellas

| By | Astellas, Japan, Laboratories
0
198

Eurofins Scientific, a global leader in biopharmaceutical products testing services, announces that it has signed an outsourcing agreement with Astellas to outsource one of its internal testing laboratories Astellas Analytical Science Laboratories, Inc. (ASL).

ASL was established in 1996 as the core pharmaceutical product testing provider for Astellas Pharma Inc., one of the largest pharmaceutical companies in Japan. ASL offers analytical testing services that allow high-quality pharmaceuticals to enter the market. The company provides quality assessment of raw materials, drug substances and preparations related to drug approval applications. It also offers quality evaluation of formulation, stability evaluation, test method validation, physicochemical testing and microbiological testing using the latest analytical instruments available, including Cell Based Assay (CBA) for antibodies. ASL is located in Kyoto and employs more than 140 staff. As part of this outsourcing program, Astellas has committed to provide ASL work covering its current capacity for an agreed period of time as the company invests in further capabilities and staff to serve a wider range of clients.

ASL will be Eurofins’ first laboratory in Japan offering test services with the Good Manufacturing Practice (GMP) standard. It will become a key laboratory for the Group’s global GMP laboratory network, counting already more than 30 GMP sites in Europe, India and the USA. This outsourcing deal with Astellas provides Eurofins with a valuable entry into the biopharmaceutical products testing market in Japan.

Eurofins is an international group of laboratories headquartered in Brussels (Belgium), providing testing and support services to the pharmaceutical, food, environmental, agriscience and consumer products industries and to governments.

SOURCE: eurofins
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.